Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 4Pain, Postoperative 2Neoplasms 2Agnosia 2Recurrence 1Postoperative Cognitive Complications 1Non-Muscle Invasive Bladder Neoplasms 1Neoplastic Cells, Circulating 1Myofibroma 1Melanoma 1Liver Neoplasms 1Leiomyoma 1Inflammatory Bowel Diseases 1Diverticulitis 1Delirium 1Colonic Neoplasms 1Cancer Surgery 1

Interventions

Tea 3Lidocaine 2polyethylene glycol 400 1Sutures 1Surgical Instruments 1Starch 1Ringer's Lactate 1Polyethylene Glycols 1Passive Cutaneous Anaphylaxis 1Occult Blood 1Neomycin 1Morphine 1Metronidazole 1Hydroxyethyl Starch Derivatives 1Glycols 1Ethanol 1Colonoscopy 1Colectomy 1Caffeine 1Bupivacaine 1Benchmarking 1Anesthesia, Spinal 1Anesthesia, Epidural 1Analgesia, Epidural 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Diverticulitis × Anesthesia, Spinal × Clear all
NCT01477190 2011-11-28

Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 1/2 Completed
40 enrolled
Gastrointestinal

Colonic Neoplasms, Diverticulitis, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡